Carregant...
Novel aspects of antiplatelet therapy in cardiovascular disease
Antiplatelet therapy is a cornerstone in the secondary prophylaxis of adverse cardiovascular events such as myocardial infarction and stroke. The cyclooxygenase inhibitor aspirin remains the most frequently prescribed antiplatelet drug, followed by adenosine diphosphate P2Y(12) receptor blockers. Gl...
Guardat en:
| Publicat a: | Res Pract Thromb Haemost |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6046593/ https://ncbi.nlm.nih.gov/pubmed/30046748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12115 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|